Biotech

All Articles

Arch closes $3B-plus fund to encourage biopharma startups

.On the heels of a $3 billion fund coming from Bain Funding Life Sciences, Arc Project Partners is a...

Orion to use Aitia's 'electronic identical twins' to locate brand-new cancer drugs

.Finnish biotech Orion has actually spied possible in Aitia's "digital identical twin" technology to...

Windtree's shock med increases blood pressure in most recent phase 2 win

.While Windtree Therapeutics has struggled to develop the monetary roots needed to endure, a phase 2...

2 cancer biotechs merge, developing worldwide footprint

.OncoC4 is taking AcroImmune-- as well as its own in-house medical manufacturing abilities-- under i...

Amgen reports initial stage 3 win for $400M dermatitis medicine

.Amgen has shared (PDF) the very first stage 3 data on its own $400 thousand dermatitis drug, connec...

Biogen, UCB file period 3 lupus gain after falling short earlier trial

.Biogen as well as UCB's bet one's bottom dollar advancing into phase 3 astride a broken research lo...

Aptadir wishes brand new RNA preventions can turn around tricky cancers cells

.Italian biotech Aptadir Therapeutics has actually released along with the assurance that its own pi...

Wave surfs DMD excellence to regulators' doors, sending out stockpile

.Wave Lifestyle Sciences has actually fulfilled its own goal in a Duchenne muscle dystrophy (DMD) st...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, using ...

Achilles droplets tissue therapy system, braces for cutbacks after missing 'office viability' objectives

.Achilles Therapeutics has destroyed its own tactic. The English biotech is actually quiting working...